Allianz SE
F:ALVE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Allianz SE
F:ALVE
|
DE |
|
L
|
Linde PLC
SWB:LIN
|
UK |
|
Evertec Inc
F:2EV
|
PR |
|
O
|
Origin Property PCL
SET:ORI
|
TH |
|
P
|
Polimex Mostostal SA
F:7F7
|
PL |
|
J
|
Julius Baer Gruppe AG
F:JGE
|
CH |
|
M
|
Main Street Capital Corp
F:13M
|
US |
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
US |
|
A
|
Assurant Inc
DUS:ZAS
|
US |
|
E
|
Elisa Oyj
XMUN:EIA
|
FI |
Wall St Price Targets
ALVE Price Targets Summary
Allianz SE
According to Wall Street analysts, the average 1-year price target for ALVE is 40.77 EUR with a low forecast of 32.23 EUR and a high forecast of 51.95 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ALVE's stock price target?
Price Target
40.77
EUR
According to Wall Street analysts, the average 1-year price target for ALVE is 40.77 EUR with a low forecast of 32.23 EUR and a high forecast of 51.95 EUR.
What is the Revenue forecast for Allianz SE?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 3 years is 6%.
What is the Net Income forecast for Allianz SE?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 8%.
